Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period

IF 3.5 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases Pub Date : 2024-12-01 DOI:10.1016/j.soard.2024.08.033

Tammy L. Kindel M.D., Ph.D. , Andrew Y. Wang M.D. , Anupama Wadhwa M.D. , Allison R. Schulman M.D., M.P.H. , Reem Z. Sharaiha M.D., M.Sc , Matthew Kroh M.D. , Omar M. Ghanem M.D. , Shauna Levy M.D., M.S. , Girish P. Joshi M.D. , Teresa L. LaMasters M.D. , American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, American Society of Anesthesiologists, International Society of Perioperative Care of Patients with Obesity, Society of American Gastrointestinal and Endoscopic Surgeons

引用次数: 0

查看原文本刊更多论文

关于在围手术期安全使用胰高血糖素样肽-1 受体激动剂的多协会临床实践指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgery for Obesity and Related Diseases 医学-外科

CiteScore

6.70

自引率

12.90%

发文量

570

审稿时长

56 days

期刊介绍： Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.